NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. (PTIX), a biopharmaceutical company developing novel neuro-active peptide therapies, today announced that it expects to ...

Quarterly Filing a Day Earlier Than Previously Stated to be Followed by CEO Interview and Investor Q&A at 4:05 PM ET ...

LAS VEGAS--(BUSINESS WIRE)-- ALT 5 Sigma Corporation (the “Company” or “ALT5”) (NASDAQ: ALTS)(FRA: 5AR1) today announced that it received a notification letter (the “Letter”) from the Nasdaq Stock ...

DeFi Development (DFDV) announced the filing of its Quarterly Report on Form 10-Q for the period ended September 30, 2025. The Company reported a gain from changes in fair value of digital assets of ...